These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11379258)

  • 1. [Carriers of chronic hepatitis B].
    Ring-Larsen H
    Ugeskr Laeger; 2001 Apr; 163(18):2469. PubMed ID: 11379258
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic hepatitis B carriers].
    Mortensen IM
    Ugeskr Laeger; 2001 Aug; 163(32):4219. PubMed ID: 11510247
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic hepatitis B carriers].
    Dupont M; Johansen JR
    Ugeskr Laeger; 2001 Aug; 163(32):4219. PubMed ID: 11510248
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis B--a viral oncogene?].
    Weis NM; Krogsgaard K
    Ugeskr Laeger; 2002 Dec; 164(50):5940-4. PubMed ID: 12553116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
    Yalçin K; Değertekin H; Alp MN; Tekeş S; Satici O; Budak T
    Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
    Yalcin K; Degertekin H; Bahcecioglu IH; Demir A; Aladag M; Yildirim B; Horasanli S; Ciftci S; Badur S
    Infection; 2004 Feb; 32(1):24-9. PubMed ID: 15007739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline on prevention and treatment of chronic hepatitis B in China (2005).
    ;
    Chin Med J (Engl); 2007 Dec; 120(24):2159-73. PubMed ID: 18167196
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children.
    Demirci F; Bayraktaroğlu Z; Karaoğlan M; Coşkun Y; Karaoğlan I; Okan V
    Turk J Gastroenterol; 2005 Dec; 16(4):188-93. PubMed ID: 16547845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B in children--diagnosis, follow-up and treatment].
    Wathne KO; Rojahn A
    Tidsskr Nor Laegeforen; 2002 Aug; 122(20):1981-4. PubMed ID: 12555442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis B screening of pregnant women and follow-up vaccination of infants with HBsAG positive mothers. A survey from the Hvidovre hospital in 1999].
    Jull MN; Weber T; Høgh B
    Ugeskr Laeger; 2001 Apr; 163(18):2482-4. PubMed ID: 11379262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of chronicity and time of disappearance of HBsAg following acute hepatitis B.
    Kuruüzüm Z; Ozgenç O; Havuk A; Coşkuner A; Ari A; Celenkoğlu N
    Hepatogastroenterology; 2009; 56(90):466-9. PubMed ID: 19579622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients.
    Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T
    J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt.
    Saudy N; Sugauchi F; Tanaka Y; Suzuki S; Aal AA; Zaid MA; Agha S; Mizokami M
    J Med Virol; 2003 Aug; 70(4):529-36. PubMed ID: 12794714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision and stability of hepatitis B virus DNA levels in chronic surface antigen carriers.
    Plentz A; Koller G; Weinberger KM; Jilg W
    J Med Virol; 2004 Aug; 73(4):522-8. PubMed ID: 15221895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Give all children vaccine against hepatitis B!].
    Weiland O
    Lakartidningen; 2001 Sep; 98(36):3780-4. PubMed ID: 11586807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic values of anti-hepatitis B core immunoglobulin M detection in asymptomatic hepatitis B surface antigen carriers.
    Ali HY; Faransawy ZE; Al-Megthab NA
    Saudi Med J; 2002 Jul; 23(7):777-81. PubMed ID: 12174223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers.
    Colson P; Borentain P; Motte A; Henry M; Moal V; Botta-Fridlund D; Tamalet C; Gérolami R
    Virology; 2007 Oct; 367(1):30-40. PubMed ID: 17573090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selective screening for hepatitis B in pregnant women in Denmark].
    Myrup C; Hansen CC; Andersen E; Hellmuth EA
    Ugeskr Laeger; 2006 Sep; 168(37):3129-31. PubMed ID: 16999917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.